Loading...
Cadila Healthcare Ltd — Anastrozole Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #7 for Anastrozole · $450.0K export value · DGFT Verified
Cadila Healthcare Ltd is the #7 Indian exporter of Anastrozole with $450.0K in export value and 9 verified shipments. Cadila Healthcare Ltd holds a 0.4% market share in Anastrozole exports across 1 countries.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $13.4M | 269 | 68.2% |
| BRAZIL | $2.1M | 44 | 10.7% |
| CANADA | $1.2M | 43 | 5.8% |
| UNITED KINGDOM | $773.5K | 56 | 3.9% |
| PHILIPPINES | $507.8K | 43 | 2.6% |
| MALTA | $361.3K | 93 | 1.8% |
| RUSSIA | $300.0K | 6 | 1.5% |
| BELGIUM | $268.3K | 19 | 1.4% |
| SRI LANKA | $198.2K | 28 | 1.0% |
| GERMANY | $121.1K | 9 | 0.6% |
India exports Anastrozole to 99 countries. The top destination is UNITED STATES (68.2%), followed by BRAZIL and CANADA.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| EVERSANA LIFE SCIENCE SERVICES | UNITED STATES | $3.7M | 89 |
| EVERSANA LIFE SCIENCES SERVICES,LLC | UNITED STATES | $2.7M | 54 |
| AUROBINDO PHARMA USA., INC, | UNITED STATES | $1.3M | 25 |
| M/S. SUN FARMACEUTICA DO BRAZIL LTD | BRAZIL | $587.3K | 15 |
| EVERSANA LIFE SCIENCES SERVICES LLC |
India exported $25.8M worth of Anastrozole through 2,238 shipments from 158 suppliers to 99 countries, serving 387 buyers globally. Cadila Healthcare Ltd contributes $450.0K to this total, accounting for 0.4% of India's Anastrozole exports.
Cadila Healthcare Ltd's average Anastrozole shipment value is $50.0K per consignment, based on 9 shipments totaling $450.0K.
Cadila Healthcare Ltd ranks #7 among 158 Indian Anastrozole exporters with a 0.4% market share. The top 3 exporters are INTAS PHARMACEUTICALS LIMITED ($10.4M), ZYDUS LIFESCIENCES LIMITED ($3.6M), EUGIA PHARMA SPECIALITIES LIMITED ($3.5M). Cadila Healthcare Ltd processed 9 shipments to 1 destination countries.
What Cadila Healthcare Ltd must comply with to export Anastrozole to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Approval Process
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | NATCO PHARMA LIMITED | $2.7M | 68 | 10 | $39.5K |
| 6 | JODAS EXPOIM PRIVATE LIMITED | $1.2M | 24 | 3 | $50.0K |
| 7 | CADILA HEALTHCARE LTD ★ | $450.0K | 9 | 1 | $50.0K |
| 9 | HETERO LABS LIMITED | $207.7K | 12 | 4 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 465 | 20.8% |
| SAHAR AIR | 391 | 17.5% |
| DELHI AIR CARGO ACC (INDEL4) | 280 | 12.5% |
| DELHI AIR | 167 | 7.5% |
| MUNDRA SEA | 90 | 4.0% |
| Bombay Air | 86 | 3.8% |
| HYDERABAD AIR | 75 | 3.4% |
| MUNDRA SEA (INMUN1) | 70 | 3.1% |
Latest developments and market context
Detailed market intelligence for Anastrozole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Cadila Healthcare Ltd's Anastrozole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
| UNITED STATES |
| $567.7K |
| 23 |
| AUROBINDO PHARMA USA INC | UNITED STATES | $400.0K | 8 |
| AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $341.5K | 7 |
| SUN FARMACEUTICA DO BRASIL LTDA RUA | BRAZIL | $300.0K | 6 |
| OOO JODAS EXPOIM | RUSSIA | $200.0K | 4 |
| BRECKENRIDGE PHARMACEUTICAL INC | UNITED STATES | $150.0K | 3 |
India's Anastrozole is purchased by 387 buyers worldwide. The top buyer is EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), followed by EVERSANA LIFE SCIENCES SERVICES,LLC and AUROBINDO PHARMA USA., INC,.
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
| $17.3K |
| 8 | CADILA HEALTHCARE LIMITED | $200.0K | 4 | 1 | $50.0K |
Cadila Healthcare Ltd ranks #7 among 158 Indian Anastrozole exporters. Average shipment value of $50.0K compared to the market average of $163.1K. The closest competitors by value are NATCO PHARMA LIMITED and JODAS EXPOIM PRIVATE LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 99+ countries, 387+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Cadila Healthcare Ltd.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Anastrozole. For current shipment-level data, contact TransData Nexus.